A $260 million trial aimed at determining the effects of combined hormone therapy (cHT) as a prevention strategy for individuals with cardiovascular disease (CVD) has resulted in a net economic gain of $37.1 billion, according to a study published in the Annals of Internal Medicine. When all was said and done the trial uncovered that […]